Literature DB >> 7664266

Comparative allelotype of in situ and invasive human breast cancer: high frequency of microsatellite instability in lobular breast carcinomas.

C M Aldaz1, T Chen, A Sahin, J Cunningham, M Bondy.   

Abstract

To better understand the timing for presentation of allelic losses in human breast carcinogenesis, we compared the allelotypic profile of 23 in situ ductal carcinomas with that of 29 invasive ductal carcinomas. We also compared the allelotype of the invasive ductal breast carcinomas with that of 23 invasive lobular breast carcinomas. These studies were performed by means of microsatellite length polymorphisms from microdissected paraffin sections. We observed that involvement of chromosome arms 1p, 3p, 3q, 6p, 16p, 18p, 18q, 22q, and possibly 6q and 11p appear to be late events in breast cancer progression because allelic losses or imbalances affecting these areas were observed with very low frequency at the in situ stage. On the other hand, allelic imbalances and losses affecting chromosome arms 7p, 16q, 17p, and 17q appear to be early abnormalities because they were observed in approximately 25-30% of ductal carcinoma in situ lesions. Allelic losses and imbalances affecting the 8p arm were frequently observed in invasive lobular breast carcinomas. It was also interesting that microsatellite instability, also known as replication error (RER) phenotype, was found to occur at a high frequency in invasive lobular breast carcinomas because 9 of 23 (39%) were RER+, compared with 7 of 52 (13.5%) RER+ of breast cancers with ductal differentiation (P = 0.012, chi 2 test). Our findings provide for the first time molecular evidence suggesting that invasive lobular breast carcinomas may arise by a different mechanism of carcinogenesis than ductal carcinomas.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7664266

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  23 in total

1.  Multiplex genotype analysis of invasive carcinoma and accompanying proliferative lesions microdissected from breast tissue.

Authors:  X Cui; H Feiner; Z Lin; H Li
Journal:  J Mol Diagn       Date:  2000-02       Impact factor: 5.568

2.  Risk factors for ductal, lobular, and mixed ductal-lobular breast cancer in a screening population.

Authors:  Amanda I Phipps; Christopher I Li; Karla Kerlikowske; William E Barlow; Diana S M Buist
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-05-25       Impact factor: 4.254

Review 3.  The application of microsatellites in molecular pathology.

Authors:  R Naidoo; R Chetty
Journal:  Pathol Oncol Res       Date:  1998       Impact factor: 3.201

Review 4.  Mannose 6-phosphate/insulin-like growth factor 2 receptor, a bona fide tumor suppressor gene or just a promising candidate?

Authors:  S A DaCosta; L M Schumaker; M J Ellis
Journal:  J Mammary Gland Biol Neoplasia       Date:  2000-01       Impact factor: 2.673

5.  Allelic imbalance on 16q in small, unifocal hepatocellular carcinoma: correlation with HBV and HCV infections and cellular proliferation rate.

Authors:  L Gramantieri; D Trerè; A Pession; F Piscaglia; L Masi; S Gaiani; A Mazziotti; L Bolondi
Journal:  Dig Dis Sci       Date:  2000-02       Impact factor: 3.199

Review 6.  WWOX: a fragile tumor suppressor.

Authors:  Morgan S Schrock; Kay Huebner
Journal:  Exp Biol Med (Maywood)       Date:  2014-12-22

Review 7.  Genetic analysis of breast cancer progression.

Authors:  S H Dairkee; H S Smith
Journal:  J Mammary Gland Biol Neoplasia       Date:  1996-04       Impact factor: 2.673

8.  Genetically abnormal clones in histologically normal breast tissue.

Authors:  P S Larson; A de las Morenas; L A Cupples; K Huang; C L Rosenberg
Journal:  Am J Pathol       Date:  1998-06       Impact factor: 4.307

Review 9.  Biological features of premalignant disease in the human breast.

Authors:  D C Allred; S K Mohsin
Journal:  J Mammary Gland Biol Neoplasia       Date:  2000-10       Impact factor: 2.673

10.  Detection of monoclonal microsatellite alterations in atypical breast hyperplasia.

Authors:  C L Rosenberg; A de las Morenas; K Huang; L A Cupples; D V Faller; P S Larson
Journal:  J Clin Invest       Date:  1996-09-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.